| Name | cym50769 | 
|---|
| Description | CYM 50769 is a non-peptidic selective antagonist of neuropeptides B and W receptor 1 (NPBWR1). CYM 50769 can attenuates the NPW-23-induced cell proliferation in ATDC5. CYM 50769 can be used for researching endochondral bone formation[1]. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 NPBWR1, GPR7[1]  | 
                        
| In Vitro | CYM 50769 (1 and 3 μM; 30 min) attenuates the NPW-23-induced ATDC5 cell proliferation in a dose-dependent manner[1]. Cell Proliferation Assay Cell Line: ATDC5 (exposed with 200 ng/mL NPW-23 for 24 h)[1] Concentration: 1 and 3 μM Incubation Time: 30 min Result: Attenuated the NPW-23-induced cell proliferation in a dose-dependent manner. | 
| References | 
| Molecular Formula | C24H17ClN2O3 | 
|---|---|
| Molecular Weight | 416.86 | 
| Exact Mass | 416.09300 | 
| PSA | 53.35000 | 
| LogP | 5.31570 |